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Summary
Centrioles are essential for the formation of microtubule-
derived structures, including cilia and centrosomes. Abnor-
malities in centrosome number and structure occur in many
cancers and are associated with genomic instability [1]. In
most dividing animal cells, centriole formation is coordi-
nated with DNA replication and is highly regulated such
that only one daughter centriole forms close to each mother
centriole [1, 2]. Centriole formation is triggered and depen-
dent on a conserved kinase, SAK/PLK4 [3–8]. Downregula-
tion and overexpression of SAK/PLK4 is associated with
cancer in humans, mice, and flies [9–11]. Here we show
that centrosome amplification is normally inhibited by deg-
radation of SAK/PK4 degradation, mediated by the SCF/
Slimb ubiquitin ligase. This complex physically interacts
with SAK/PLK4, and in its absence, SAK/PLK4 accumulates,
leading to the striking formation of multiple daughter centri-
oles surrounding each mother. This interaction is mediated
via a conserved Slimb bindingmotif in SAK/PLK4, mutations
of which leads to centrosome amplification. This regulation
is likely to be conserved, because knockout of the ortholog
of Slimb, b-Trcp1 in mice, also leads to centrosome amplifi-
cation [12]. Because the SCF/b-Trcp complex plays an
important role in cell-cycle progression, our results lead to
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5These authors contributed equally to this worknew understanding of the control of centrosome number
and how it may go awry in human disease.
Results and Discussion
Two ubiquitin ligases, the SKP1-CUL1-F-box-protein (SCF)
complex and the anaphase-promoting complex/cyclosome
(APC/C), ubiquitylate many cell-cycle regulators, assuring
irreversibility in cell-cycle transitions [13, 14]. Previous work
suggested the SCF complex and protein degradation to be im-
portant players in the control of centrosome number [15–18].
These complexes comprise three polypeptides—Skp1 (SkpA
in Drosophila), Cullin1/3, and Roc1/Rbx1—and a fourth vari-
able adaptor that recognizes substrates, the F-box protein
[13, 19]. Skp1 and Cul1 localize to the centrosome [17].
Furthermore, depletion of SkpA and the F-box protein, Slimb
in Drosophila and its ortholog b-Trcp1 in mice, leads to a dra-
matic increase in centrosome number and abnormal mitotic
spindles [12, 15, 16]. However, these results may not reflect
direct regulation of centriole number but merely the diverse
roles of the SCF complex in cell-cycle control [13]. This led
us to investigate the role of protein degradation in centriole
biogenesis, and in particular, the role of the SCF/Slimb
complex.
We first investigated changes in centrosome number in
cultured Drosophila cells after depletion of Slimb and SkpA.
We used Geminin, an inhibitor of licensing of DNA replication,
as a positive control for changes in centrosome number. This
is because depletion of Geminin in human cells leads to DNA
rereplication, associated with centrosome amplification [20].
Indeed, Geminin RNAi led to an increase in the proportion of
cells with more than two centrosomes in Drosophila cells (Fig-
ures S1A and S1B available online) and large nuclei as ex-
pected after DNA rereplication (Figures S1A, S2A, and S2B).
RNAi of Slimb and SkpA in the same time-frame resulted in
changes in cell-cycle profile (Figures S1C and S1D) and a sim-
ilar increase in the proportion of cells with more than two cen-
trosomes (Figures S1A and S1B). An increase in centrosome
number after Slimb and SkpA depletion could result from
aborted mitosis, aborted cytokinesis, or a block in S phase,
and so be independent of direct changes in the centrosome
duplication machinery. The different cell-cycle profiles seen
after downregulation of SkpA and Slimb (Figure S1D) are likely
to reflect the diverse roles played by multiple SkpA-containing
SCF complexes in the degradation of several cell-cycle regula-
tors [13]. Those differences and the lack of any significant in-
crease in the proportion of mitotic (not shown) and polyploid
cells after Slimb depletion (Figures S1D and S2B) suggest
that the observed increase in centrosome number is unlikely
to arise indirectly because of abnormal cell-cycle progression.
We therefore conclude that downregulation ofSkpA orSlimb is
likely to lead to impaired degradation of a common substrate
that regulates centriole duplication with consequent centro-
some amplification. Strikingly, depletion of Slimb led to
a very specific phenotype at the electron microscope level
(Figure 1A). We observed more than one daughter centriole
budding from a single mother, which is not normally seen in
cycling cells, where there is strict limit to one single daughter
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44Figure 1. SAK/PLK4 Degradation Is Mediated by the SCF/Slimb-E3 Ubiquitin Ligase
(A) Transmission electron micrographs (TEM) reveal the growth of more than one procentriole close to the mother centriole in cells depleted from Slimb, but
not in the GFP RNAi control. Scale bar represents 0.250 mm.
(B) RNAi for two components of the SCF/Slimb ubiquitin ligase complex (SkpA, Slimb) stabilizes SAK/PLK4 protein. pMT-ProtA-SAK cells were transfected
with dsRNAs; SAK/PLK4 expression was induced for 15 hr before harvesting. Cells were not synchronized. Note that RNAi of two other F-box proteins
(Ago and D-Fbxw5) or Geminin did not lead to an increase in SAK/PLK4 levels.
(C) Slimb RNAi stabilizes SAK/PLK4 protein. pMT-ProtA-SAK cells were transfected with dsRNA and induced for 15 hr (see Supplemental Experimental
Procedures). Cells were washed at time zero and harvested at the indicated time points.
(D and E) SAK/PLK4 endogenous levels at centrosomes were measured in metaphase cells afterSlimb andGFPRNAi. SAK/PLK4 (green), D-PLP (Pericentrin
Like Protein, red; centrosome marker), a-tubulin (blue). All images were acquired with the same light intensity and camera exposure. Raw images are shown.
Insets show the centrosome area (1.83magnification), where contrast has been optimized for purposes of showing the presence of SAK/PLK4 signal. Scale
bar represents 10 mm.per mother centriole. A similar phenotype is also observed
upon overexpression of SAK/PLK4 and SAS-6 [3, 7, 21], a mol-
ecule known to be downstream of SAK/PLK4 and to induce
centrosome amplification upon overexpression [5, 21, 22].
Those rosette-like structures are reminiscent to the ones ob-
served in multiciliated epithelial cells, which express high
levels of SAK/PLK4 and SAS-6 [23, 24], and where as many
as 300 centrioles/basal bodies are formed per cell.
We investigated whether the SCF/Slimb complex was
targeting SAK/PLK4 or SAS-6 for degradation by asking
whether their protein levels were higher in the absence ofSlimb or SkpA. Because the levels of endogenous SAK/PLK4
are extremely low and difficult to detect by western blotting
[6, 7], we used a stable cell line in which SAK/PLK4 was fused
with Protein A and could be expressed from the inducible
metallothionein promoter. We investigated levels of SAK/
PLK4 after induction of its expression by culture in medium
containing CuSO4 for 15 hr. SAK/PLK4 levels were consider-
ably higher after downregulation of SkpA and Slimb, but not
of Geminin or other F-box proteins (Figure 1B; Figure S2C).
The increase in levels of SAK/PLK4 that we see after downre-
gulation of the SCF/Slimb complex contrasts with the lack of
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(A) Expression of a Slimb mutant lacking the Fbox (Slimb DF) leads to accumulation of SAK/PLK4 protein. pMT-ProtA-SAK cell line was transiently
transfected with act5-HA, act5-Slimb-HA, or act5-Slimb DF-HA constructs and cell extracts were prepared after a 15 hr induction of SAK/PLK4 expression.
Controls for transfection were performed with an HA antibody (not shown).
(B and C) Centrosome amplification observed after depletion of Slimb and SkpA is dependent on SAK/PLK4.
(B) Cells were treated with dsRNA (indicated) and assayed for centrosome numbers. Quantitation of supranumerary centrosomes after RNAi. Results were
normalized relative to controls (ratio is equal to 1 inGFP controls). Data are the average of three RNAi experiments6 SEM (n = 200 cells in each experiment).
(C) D-PLP (red) and DNA (blue). Scale bar represents 10 mm.effect on the levels of SAS-6 protein (Figure S3). This result is
consistent with a recent report that human SAS-6 is degraded
by the APC/Cdh1 [21] and suggests that the centrosome am-
plification observed after Slimb depletion is due to impaired
SAK/PLK4 degradation.
We further investigated the regulation of SAK/PLK4 levels by
the SCF/Slimb complex. We followed SAK/PLK4 levels during
a period of 8 hr after induction of its expression for 15 hr,
with subsequent removal of CuSO4 prior to the time course.
Whereas SAK/PLK4 degradation had commenced 4 hr after
removal of CuSO4 from control cells, its degradation began
only after 8 hr in Slimb-depleted cells (Figure 1C). We verified
this result investigating the endogenous SAK/PLK4 by devel-
oping a sensitive immunocytochemical detection system for
this protein. SAK/PLK4 levels and localization might be cell-
cycle regulated, as they are for other members of the polo
kinase family, so we made all comparisons by examining cells
at the same cell-cycle stage (metaphase). Slimb depletion
resulted in an increase in the levels of the endogenous SAK/
PLK4 at the centrosome and the whole cell, and thus our
results are unlikely to reflect abnormal localization properties
of SAK/PLK4 (Figures 1D and 1E; Figures S4 and S5A). This
is also unlikely to be an indirect consequence of an increasein the number of centrosomes at each pole after Slimb RNAi,
because we also saw more intense SAK/PLK4 staining without
any increase in the size of poles (Figure S5B, upper pole). This
suggests that the centrosome amplification seen after Slimb
RNAi results from an increase in SAK/PLK4 levels. To further
verify these results, we used a dominant-negative approach.
Slimb binds to SkpA through its F-box and mutants in this
domain have been shown to impair SCF/Slimb function [25].
Indeed, we observed elevated levels of the SAK/PLK4 protein
after expression of such a mutant (Figure 2A), which is accom-
panied by more than a 2-fold increase in the proportion of cells
with more than two centrosomes (68.26 1.1 after transfection
of Slimb DF-HA versus 32.3 6 2.5 with HA alone).
If Slimb is targeting SAK/PLK4 for degradation, then the
increase in centrosome number seen after impairment of Slimb
function should depend on SAK/PLK4. We performed double
RNAi ofSAK/PLK4 and eitherSlimborSkpA. We observed a re-
duction in centrosome number after bothSlimb andSAK/PLK4
RNAi, and after both SkpA and SAK/PLK4 RNAi, as compared
to Slimb and SkpA alone, suggesting that the phenotype
observed after depletion of the Slimb and SkpA is dependent
on the presence of SAK/PLK4, corroborating our hypothesis
(Figures 2B and 2C).
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(A) Proteasome inhibition stabilizes SAK/PLK4 protein. pMT-ProtA-SAK cells were induced for 15 hr with CuSO4, after which they were washed and
incubated with vehicle (DMSO) or the proteasome inhibitor MG132. Cells were harvested at the indicated time points.
(B and C) Wild-type cells were treated with MG132 for 6 hr and stained for endogenous SAK (green), a-tubulin (blue), and D-PLP (red).
(B) Images were acquired and are shown as in Figure 1D. Scale bar represents 10 mm.
(C) Quantitation of the average intensity of SAK/PLK4 signal per pixel at the centrosomes as in Figure 1E.
(D and E) Treatment with MG132 led to centrosome amplification.
(D) Cells were fixed and stained for a-tubulin (blue) and D-PLP (red).
(E) The proportion of cells in interphase with more than two centrosomes was counted. Note that controlDrosophila tissue-culture cells show a background
population with more than two centrosomes (approximately 30%) as reported before [34].SCF ubiquitin ligases tag proteins with a polyubiquitin chain
that targets them for degradation by the 26S proteasome
[19]. We tested whether SAK/PLK4 is degraded by the 26S pro-
teasome. We observed degradation of SAK/PLK4 in the
absence but not in the presence of MG132, a 26S proteasome
inhibitor, for 8 hr (Figure 3A). We observed an approximate
3-fold increase in the levels of endogenous SAK/PLK4 at the
metaphase centrosome when we inhibited proteasome activ-
ity (Figures 3B and 3C). This was also reflected in the total
centrosome number, as cells accumulated centrosomes after
such MG132 treatment (Figures 3D and 3E). Together, theseresults strongly suggest that SAK/PLK4 is degraded by the
proteasome and that impairment of this regulation leads to
centrosome amplification.
F-box proteins are known to bind directly to SCF substrates
through a WD40 repeat motif [13]. To determine whether there
is an association between SAK/PLK4 and Slimb, we built two
cell lines in which these proteins were tagged with Protein A.
We used immunoglobulin-coated beads to purify each of
these proteins and the proteins associated with them. Com-
plexes were subjected to SDS-PAGE and individual bands
identified by mass spectrometry. We were able to identify
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(A) SAK/PLK4 interacts with Slimb. Pull-down of ProtA-SAK and Slimb-ProtA fusion proteins, followed by SDS-PAGE and sequencing of approximately
20–30 excised bands. The number of times each interacting protein appeared, the maximum MASCOT score, and the number of identified peptides for
each interacting protein are indicated. These interactions have been reproduced at least five times in independent experiments.
(B) Consensus degron in SAK/PLK4 sequence for Slimb recognition. Position of first amino acid residue shown in sequence is indicated in brackets. Degron
is indicated in red and mutated sites are in blue.
(C) Western blot of pull-down of ProtA from cell lines expressing both ProtA-SAK (inducible) and Slimb-Myc (constitutive) or both ProtA-SAK-ND (inducible)
and Slimb-Myc (constitutive). S, input/supernatant after cell lysis; E, bead eluate; protein ladder is in middle lane (marked by asterisk). Western was first
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48members of the Slimb/SCF complex, including the subunits
Slimb, SkpA, and Cul-1, after pull-down of SAK/PLK4 (Fig-
ure 4A). Conversely, endogenous SAK/PLK4 was identified in
the pull-down of protein-A-tagged Slimb (Figure 4A). The
pull-down included other proteins (data not shown) among
which was Period, a known interactor of Slimb [25]. We have
used a cell line expressing protein A as a negative control
and did not find any of those molecules (data not shown).
Moreover, we have performed similar experiments to purify
other cell-cycle protein complexes and have never identified
SAK/PLK4 (data not shown).
Substrates of the SCF/Slimb complex show a conserved de-
gron that is recognized by Slimb [13]. We found that SAK/PLK4
protein has a modified Slimb recognition site in Drosophila
(DSGIIT; position 293) and humans (DSGHAT; position 285)
(Figure 4B). In previous studies, human SAK/PLK4 was shown
to be ubiquitinated [26] and removal of a region encompassing
amino acids 272–311 led to stabilization of the human SAK/
PLK4, although no analysis was performed on centrosome
number [27]. We mutated the conserved Slimb recognition
site to DAGIIA in Drosophila SAK/PLK4, which we called
SAK-ND (nondegradable). This mutation abolished SAK’s abil-
ity to interact with Slimb (Figures 4B and 4C; Figure S6A) and
led to a decrease in SAK’s ubiquitinated species (Figure S6B).
Moreover, SAK-ND is more stable in comparison to its WT
counterpart (Figure 4D). Thus, this mutation allowed us to
test the biological significance of SAK/PLK4 degradation by
the SCF/Slimb complex. Upon expression of the mutated
SAK/PLK4 construct (Figure 4E), we observed a very similar
phenotype to the one registered after Slimb RNAi (Figure 1A),
i.e, rosette-like structures. These structures contained centri-
ole percursors (Figure 4E, top) or elongating centrioles (Fig-
ure 4E, middle and bottom). Those results suggest a common
centriole-amplification phenotype observed after Slimb
RNAi and after expression of the SAK-ND mutant. The
observation of at least five centrioles clustered at spindle
poles in mitosis suggests that some of the supranumerary
centrioles formed in one cycle after impairment of SAK/PLK4
degradation by the SCF/Slimb complex become proper
microtubule-organizing centers (Figure S6C). We quantified
the formation of supranumerary centrosomes at the light
microscope level. Upon transient low-level expression of the
SAK-ND construct fused to GFP, we systematically observed
a statistical significant increase in centrosome number in
transfected cells compared to cells expressing low levels of
the WT SAK fused to GFP (Figure 4F; Figure S6D). Indeed,
expression of low levels of SAK-ND led to a 2-fold increase
in centrosome amplification (Figure 4F). This is comparable
to the effect of Slimb RNAi (Figure S1B) and after expression
of a dominant-negative form of Slimb (referred to above),suggesting that high levels of SAK/PLK4 underlie those
phenotypes.
Together, our results show that degradation of SAK/PLK4
by the SCF/Slimb complex is critical to restrict its function,
preventing centrosome amplification. Although other mecha-
nisms for regulation of SAK/PLK4 activity may exist, proteo-
lytic degradation is likely to be conserved across species
and be relevant in the animal. The Slimb-binding phosphode-
gron in SAK/PLK4 is conserved in vertebrates (Figure 4B).
Moreover, knockout of the ortholog of Slimb in mice, b-
Trcp1, and both SkpA and Slimb Drosophila mutants show
an increase in centrosome number [12, 15, 16], as do flies
that overexpress SAK/PLK4 [4, 5, 10].
It has been suggested that centriole overduplication is nor-
mally prevented by a ‘‘licensing event,’’ the disengagement of
centrioles that occurs at the exit of mitosis, required for the
next duplication cycle [28, 29]. Requirement for this event
ensures that centrioles duplicate only once in every cell cycle.
However, it was recently shown that centriole amplification
can also occur through the simultaneous formation of many
daughters from a single mother, as it is after overexpression
of SAK/PLK4 [3–5, 7] and SAS-6 [21] or inhibition of proteolysis
by the proteosome [18]. Our data suggests that proteolysis
mediated by SCF/Slimb plays an important role in limiting
the amount of SAK/PLK4, but not SAS-6, available to trigger
multiple daughter formation. When SAK/PLK4 is not de-
graded, multiple daughter centrioles may be generated, which
led to centrosome amplification (Figures 4E, 4F, and 4G). The
regulation of centriole number thus emerges as a multistep
mechanism, where proteolysis controls the activity of key
players, SAK/PLK4 and SAS-6 [18, 21].
The mammalian F-box counterpart of Slimb, b-Trcp, plays
a role in the DNA damage response by halting the cycle in
response to genotoxic inputs [30–32]. Misregulation of
b-Trcp has been observed in cancer cells [13, 33] in which
centrosome number is often increased after stress [1]. It is
thus possible that Slimb/b-Trcp coordinates checkpoints
that monitor the status of DNA replication with centrosome
number. The misregulation of this F-box protein would there-
fore result in changes in levels of SAK/PLK4, which are asso-
ciated with mitotic abnormalities and oncogenesis [6, 9, 10].
Given that other substrates of the Slimb/b-Trcp F-box protein
require to be phosphorylated and our own results with the
SAK-ND mutant (Figures 4C–4E), it is likely that SAK/PLK4
also requires such a modification at the serine and threonine
residues in its DSGIIT degron to mark it for degradation.
Future research on the identity and regulation of the kinase
that phosphorylates SAK/PLK4 and on the localization of
Slimb and SAK/PLK4 phosphorylated at the DSGIIT degron
should indicate how different signaling events areprobed for Myc to detect Slimb-Myc and then for protein A to show SAK and SAK-ND. a-tubulin was used as a loading control. Note that both cell lines
express similar levels of Slimb-Myc and ProtA-SAK or ProtA-SAK-ND (see Figure S6A), but that the latter brings down much less Slimb-Myc.
(D) Cells were transfected transiently with pMT-GFP-SAK and pMT-GFP-SAK-ND and induced for 15 hr (see Supplemental Experimental Procedures). Cells
were washed at time zero, split into different wells, and harvested at the indicated time points. Note the stabilization of SAK-ND.
(E) Transmission electron micrographs (TEM) of GFP-SAK-ND cells reveal the growth of multiple procentrioles around a single mother. Scale bar represents
0.250 mm.
(F) Cells transfected transiently with pMT-GFP-SAK and pMT-GFP-SAK-ND, with no CuSO4 induction, were stained for centrosomes (D-PLP) for counts (see
Figure S6D for images). The proportion of cells with more than two centrosomes in interphase cells was counted and normalized over controls (ratio is equal
to 1 in GFP-only transfected controls). Data are the average of three experiments 6 SEM. The increase in the population of cells with more than two
centrosomes after SAK-ND transfection is statistically different from the one observed after transfection of WT SAK/PLK4 (odds ratio of 3.5; p < 10215,
Pearson’s c2 test)
(G) Regulation of the levels of SAK/PLK4 by the SCF/Slimb complex. The levels of SAK/PLK4 have to be very well controlled. Overexpression of SAK/PLK4,
or depletion of the SCF/Slimb complex, which led to SAK/PLK4 accumulation, results in centrosome amplification through simultaneous multiple
procentriole formation.
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49coordinated in the cell to prevent centrosome amplification.
Our results open new avenues for understanding the mecha-
nisms underlying centrosome misregulation that are of direct
relevance to human disease.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, six
figures, and two tables and can be found with this article online at http://
www.current-biology.com/supplemental/S0960-9822(08)01554-6.
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